KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilent Technologies (A) Research & Development (2016 - 2026)

Agilent Technologies has reported Research & Development over the past 17 years, most recently at $117.0 million for Q1 2026.

  • Quarterly Research & Development rose 3.54% to $117.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $459.0 million through Jan 2026, down 1.08% year-over-year, with the annual reading at $455.0 million for FY2025, 5.01% down from the prior year.
  • Research & Development was $117.0 million for Q1 2026 at Agilent Technologies, down from $119.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $128.0 million in Q1 2024 and troughed at $111.0 million in Q4 2024.
  • The 5-year median for Research & Development is $117.0 million (2022), against an average of $117.6 million.
  • Year-over-year, Research & Development grew 13.59% in 2022 and then fell 12.6% in 2025.
  • A 5-year view of Research & Development shows it stood at $119.0 million in 2022, then fell by 4.2% to $114.0 million in 2023, then decreased by 2.63% to $111.0 million in 2024, then grew by 7.21% to $119.0 million in 2025, then decreased by 1.68% to $117.0 million in 2026.
  • Per Business Quant, the three most recent readings for A's Research & Development are $117.0 million (Q1 2026), $119.0 million (Q4 2025), and $111.0 million (Q3 2025).